Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0379519990150030369
Çѱ¹µ¶¼ºÇÐȸÁö
1999 Volume.15 No. 3 p.369 ~ p.372
Protective Effect of BR92021, Vi Polysaccharide Typhoid Vaccine, in Mice
Lim Sang-Min

Jung Hahn-Sun
Lee Youn-Kyeong
Cho Zeung-Keun
Kim Sang-Lin
Lee Yong-Soon
Abstract
This study was performed to confirm the immunological efficacy of BR92021, vi polysaccharide typhoid vaccine, in mice. The BR92021 producing strain was less pathogenic than the challenging organism, S. typhi ty2 N4446. BR92021 completely protected the death caused by S. typhi ty2 at above 1.25 §¶/0.5 ml/dose vaccinized by one time. At the optimally effective dose of 25 §¶/0.5 ml of BR92021, one immunization was necessary for complete protection against S. typhi ty2-induced death. In potency test, we injected S. typhi ty2 N4446 (LD50=7.9)for the purpose of challenge to immunized mice. When injected to mice, the number of bacteria was about 1,000 CFU/0.5 ml, we observed challenged mouse for 3 days and calculated the ED50 by probits method. It was 0.037 (BR92021 ,lot No. 980001), 0.036 (BR92021, lot No. 980002), 0.032 (BR92021, lot No. 980003) and 0.045 (reference standard) §¶/0.5 ml/mouse. This result showed that BR92021 vaccine was effective for the protection from desease caused by S. typhi ty2 infection.
KEYWORD
BR92021, Vi polysaccharide typhoid vaccine, Immunological efficacy
FullTexts / Linksout information
 
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed